Kennedy Kevin R 4
4 · Bank of Marin Bancorp · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Bank of Marin (BMRC) Director Kevin R. Kennedy Receives 849 Shares
What Happened
Kevin R. Kennedy, a director of Bank of Marin Bancorp (BMRC), received 849 shares on July 1, 2026. The filing shows an acquisition at $28.94 per share, reported with a total value of $24,570. This was a non-market compensation receipt (director fee), not an open‑market purchase.
Key Details
- Transaction date: 2026-07-01; price per share: $28.94; shares: 849; reported value: $24,570.
- Transaction code: J (other acquisition or disposition).
- Footnote: F1 — "Shares received in payment of Director fee."
- Shares owned after the transaction: not provided in the supplied filing details.
- Filing timeliness: Reported and filed on 2026-07-01 (timely).
Context
Receiving shares as director compensation is routine and reflects pay structure rather than a direct buy/sell market sentiment. Such receipts are informative about how the company compensates directors but should not be interpreted alone as a bullish insider purchase.
Insider Transaction Report
- Other
Common Stock
[F1]2026-07-01$28.94/sh+849$24,570→ 30,050 total(indirect: By Trust)
- 958
Stock Options (Right to Buy)
Exercise: $40.70From: 2018-07-02Exp: 2028-07-02→ Common Stock (958 underlying) - 988
Stock Options (Right to Buy)
Exercise: $41.35From: 2019-01-02Exp: 2029-01-02→ Common Stock (988 underlying) - 1,077
Stock Options (Right to Buy)
Exercise: $41.80From: 2019-07-01Exp: 2029-07-02→ Common Stock (1,077 underlying) - 1,019
Stock Options (Right to Buy)
Exercise: $44.85From: 2020-01-02Exp: 2030-01-02→ Common Stock (1,019 underlying) - 1,279
Stock Options (Right to Buy)
Exercise: $32.20From: 2020-07-01Exp: 2030-07-01→ Common Stock (1,279 underlying) - 2,479
Stock Options (Right to Buy)
Exercise: $32.41From: 2021-07-01Exp: 2031-07-01→ Common Stock (2,479 underlying) - 1,030
Stock Options (Right to Buy)
Exercise: $37.35From: 2022-01-03Exp: 2032-01-03→ Common Stock (1,030 underlying) - 1,205
Stock Options (Right to Buy)
Exercise: $32.55From: 2022-07-01Exp: 2032-07-01→ Common Stock (1,205 underlying) - 2,317
Stock Options (Right to Buy)
Exercise: $32.54From: 2023-01-03Exp: 2033-01-03→ Common Stock (2,317 underlying)
Footnotes (1)
- [F1]Shares received in payment of Director fee